Your session is about to expire
← Back to Search
Abiraterone + Prednisone for Prostate Cancer (APRE Trial)
APRE Trial Summary
This trial will study how well standard prostate cancer treatments work in different ethnic groups.
APRE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAPRE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.APRE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had surgery over 2 weeks ago and have recovered from major side effects.I am taking or plan to take bone-strengthening drugs that don't affect PSA levels.I had a full physical exam and discussed my medical history with a doctor within the last 28 days.I've had scans of my cancer within the last 42 days.I can take care of myself, but may not be able to do heavy physical work. If I'm less active, it's only because of bone pain.I have advanced prostate cancer and cannot or will not undergo docetaxel treatment.I have prostate cancer that has spread, and I haven't started hormone therapy yet.My heart's electrical activity is normal as per my recent ECG.My kidney function is good, with a creatinine clearance rate of at least 40 mL/min.I am 18 years old or older.I do not have brain metastases.I have no cancer history, except for certain skin cancers, early-stage cancers in remission, or any cancer I've been free from for 5 years.I haven't had chemotherapy for metastatic prostate cancer but may have had it earlier with a curative goal.I've had hormone therapy for cancer that didn't last over 36 months and it's been 6 months since my last treatment.My liver is functioning well according to recent tests.My blood tests meet the required levels for white blood cells, neutrophils, hemoglobin, and platelets.I started hormone therapy for prostate cancer less than 42 days ago and am willing to switch or continue treatment as required.I am not allergic to abiraterone or LHRH agonists.I don't have severe heart failure or recent serious heart problems.I am not taking and have no plans to take ketoconazole, aminoglutethimide, or enzalutamide.I do not have a history of adrenal insufficiency.I don't have GI conditions that affect medication absorption.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the usual indications for this therapy?
"This medical intervention is not only useful for treating thyroiditis, but can also be effective in combating ulcerative colitis, malignant neoplasms, and varicella-zoster virus acute retinal necrosis."
Are there any open positions for volunteers in this clinical trial?
"That is correct. The clinicaltrials.gov website indicates that this trial, which was initially posted on May 23th 2019 and edited most recently on October 7th 2020, is currently recruiting patients. They are aiming to enroll 130 people from 3 different locations."
How many people can enroll in this research project?
"Yes, the information on clinicaltrials.gov indicates that this trial is recruiting patients. The trial was initially posted on 5/23/2019 and was most recently edited on 10/7/2022. The study is looking for 130 participants at 3 locations."
Is this a common treatment that has been well-researched?
"There are 378 total trials currently running that investigate this treatment, with 101 of those being in Phase 3. Duarte, California has the most studies for this treatment (n=?), but there are 17174 locations worldwide where these studies are taking place."
Has this intervention received the FDA's green light?
"While Phase 2 trials don't have any data supporting efficacy, this treatment still received a score of 2 for safety."
Share this study with friends
Copy Link
Messenger